MELBOURNE – In a new feature, PharmAsia News combs through earnings reports to bring you highlights on Australian biotech firms. We start with CSL Ltd., Acrux Ltd., Pharmaxis Ltd. and Mesoblast Ltd. for the period ended Dec. 31, 2012.
Blood plasma and vaccine giant CSL said it will continue to invest more in emerging markets. “It’s been a very...